Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
Clinical trial NCT00932828 · COMPLETED
Trial details
- NCT number
- NCT00932828
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-22
- Primary completion
- 2017-02-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.